Complicated third sternotomy for left ventricular outflow tract obstruction secondary to mitral valve prosthesis strut.

Rishab Agarwal, AlleaBelle Bradshaw, Michelle Carvajal, Jennifer S Lawton
{"title":"Complicated third sternotomy for left ventricular outflow tract obstruction secondary to mitral valve prosthesis strut.","authors":"Rishab Agarwal, AlleaBelle Bradshaw, Michelle Carvajal, Jennifer S Lawton","doi":"10.21542/gcsp.2026.13","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction</b>: LVOT obstruction after surgical bioprosthetic MVP placement is uncommon and the influence of the MVP strut width has seldom been examined. <b>Case presentation</b>: A 74-year-old female presented with palpitations, chest pain, and shortness of breath. She had MVR with 31-mm bioprosthetic valve 2 years prior. TEE confirmed LVOT obstruction secondary to a MVP strut, causing a peak gradient of 55 mmHg. The redo operation was complicated by iatrogenic Type A aortic dissection. The patient was immediately cooled for DHCA with RCP and ascending aortic replacement was performed. MVR was then performed with a prosthesis with narrower strut width. Recovery after surgery was uneventful and post-bypass TEE confirmed absence of LVOT obstruction (gradient of 4 mmHg). <b>Discussion</b>: This case is of interest for two reasons. Primarily, the overall profile of the valve, including the width of the struts may play a significant role in the development of LVOT obstruction after MVR. Additionally, the patient had an ITAAD requiring prompt and thoughtful management. <b>Conclusions</b>: This case underscores the importance of evaluating MVP profile in relation to patient anatomy. Furthermore, intraoperative Type A aortic dissection is a rare but lethal phenomenon requiring swift decision-making and technical ability, and both are important considerations for trainees.</p>","PeriodicalId":12669,"journal":{"name":"Global Cardiology Science & Practice","volume":"2026 2","pages":"e202613"},"PeriodicalIF":0.0000,"publicationDate":"2026-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13197850/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Cardiology Science & Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21542/gcsp.2026.13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: LVOT obstruction after surgical bioprosthetic MVP placement is uncommon and the influence of the MVP strut width has seldom been examined. Case presentation: A 74-year-old female presented with palpitations, chest pain, and shortness of breath. She had MVR with 31-mm bioprosthetic valve 2 years prior. TEE confirmed LVOT obstruction secondary to a MVP strut, causing a peak gradient of 55 mmHg. The redo operation was complicated by iatrogenic Type A aortic dissection. The patient was immediately cooled for DHCA with RCP and ascending aortic replacement was performed. MVR was then performed with a prosthesis with narrower strut width. Recovery after surgery was uneventful and post-bypass TEE confirmed absence of LVOT obstruction (gradient of 4 mmHg). Discussion: This case is of interest for two reasons. Primarily, the overall profile of the valve, including the width of the struts may play a significant role in the development of LVOT obstruction after MVR. Additionally, the patient had an ITAAD requiring prompt and thoughtful management. Conclusions: This case underscores the importance of evaluating MVP profile in relation to patient anatomy. Furthermore, intraoperative Type A aortic dissection is a rare but lethal phenomenon requiring swift decision-making and technical ability, and both are important considerations for trainees.

合并第三胸骨切开术治疗二尖瓣假体支架继发左室流出道梗阻。
生物假体植入MVP后LVOT阻塞并不常见,MVP支撑宽度的影响很少被研究。病例介绍:一名74岁女性,表现为心悸、胸痛和呼吸短促。2年前,她接受了带有31毫米生物假体瓣膜的MVR。TEE确认LVOT阻塞继发于MVP支柱,导致峰值梯度为55mmhg。重做手术并发医源性A型主动脉夹层。患者立即冷却DHCA和RCP,并进行升主动脉置换术。然后使用较窄支撑物宽度的假体进行MVR。术后恢复平稳,搭桥后TEE确认无LVOT梗阻(梯度为4mmhg)。这个案例引起人们的兴趣有两个原因。首先,瓣膜的整体轮廓,包括支板的宽度可能在MVR后LVOT阻塞的发展中起重要作用。此外,患者患有ITAAD,需要及时周到的治疗。结论:本病例强调了评估MVP剖面与患者解剖结构的重要性。此外,术中A型主动脉夹层是一种罕见但致命的现象,需要快速的决策和技术能力,这两者都是学员的重要考虑因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Global Cardiology Science & Practice
Global Cardiology Science & Practice Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.60
自引率
0.00%
发文量
20
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书